Archived documents
Documents past their public comment period for Pharmaceutical Policy.
PSG_219019 - Draft Guidance on Fitusiran Sodium
0 comments
Analysis in progress
Top issues in comments
PSG_021247 - Draft Guidance on Flunisolide
0 comments
Analysis in progress
Top issues in comments
PSG_021433 - Draft Guidance on Fluticasone Propionate
0 comments
Analysis in progress
Top issues in comments
PSG_021254 - Draft Guidance on Fluticasone Propionate; Salmeterol Xinafoate
0 comments
Analysis in progress
Top issues in comments
PSG_208294 - Draft Guidance on Formoterol Fumarate; Glycopyrrolate
0 comments
Analysis in progress
Top issues in comments
PSG_022518 - Draft Guidance on Formoterol Fumarate; Mometasone Furoate
0 comments
Analysis in progress
Top issues in comments
PSG_217779 - Draft Guidance on Imetelstat Sodium
0 comments
Analysis in progress
Top issues in comments
PSG_021527 - Draft Guidance on Ipratropium Bromide
0 comments
Analysis in progress
Top issues in comments
PSG_215974 - Draft Guidance on Lenacapavir Sodium
0 comments
Analysis in progress
Top issues in comments
PSG_021730 - Draft Guidance on Levalbuterol Tartrate
0 comments
Analysis in progress
Top issues in comments
PSG_008816 - Draft Guidance on Lidocaine Hydrochloride
0 comments
Analysis in progress
Top issues in comments
PSG_021850 - Draft Guidance on Magnesium Hydroxide; Omeprazole; Sodium Bicarbonate
0 comments
Analysis in progress
Top issues in comments